We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.54%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$1.58B
AUM Growth
+$92.6M
Cap. Flow
+$199M
Cap. Flow %
12.58%
Top 10 Hldgs %
29.03%
Holding
140
New
2
Increased
50
Reduced
52
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Healthcare 16.21%
3 Industrials 15.07%
4 Materials 8.3%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRMB icon
51
Trimble
TRMB
$13.6B
$3.1M 0.2%
79,865
-385
-0.5% -$13.9K
CLB icon
52
Core Laboratories
CLB
$519M
$2.5M 0.16%
12,620
-290
-2% -$54.7K
PII icon
53
Polaris
PII
$4B
$2.48M 0.16%
17,760
-140
-0.8% -$18.9K
MKL icon
54
Markel Group
MKL
$23.2B
$2.4M 0.15%
4,025
-60
-1% -$34.2K
IHS
55
DELISTED
IHS INC CL-A COM STK
IHS
$2.27M 0.14%
18,685
-260
-1% -$30.7K
MCRS
56
DELISTED
MICROS SYSTEMS INC
MCRS
$2.25M 0.14%
42,555
-205
-0.5% -$11.4K
DCI icon
57
Donaldson
DCI
$11.4B
$2.19M 0.14%
51,775
-85
-0.2% -$3.58K
CPRT icon
58
Copart
CPRT
$26.6B
$2.18M 0.14%
479,160
-520
-0.1% -$2.31K
OII icon
59
Oceaneering
OII
$4.94B
$2.18M 0.14%
30,330
+260
+0.9% +$18.6K
GGG icon
60
Graco
GGG
$13.4B
$2.09M 0.13%
83,871
-600
-0.7% -$15K
SM icon
61
SM Energy
SM
$6.91B
$2.03M 0.13%
28,530
+4,330
+18% +$339K
IPGP icon
62
IPG Photonics
IPGP
$3.78B
$1.6M 0.1%
22,565
-555
-2% -$39K
ANSS
63
DELISTED
Ansys
ANSS
$1.53M 0.1%
19,876
-210
-1% -$17K
UAA icon
64
Under Armour
UAA
$2.78B
$1.3M 0.08%
45,340
-3,820
-8% -$99.9K
GNTX icon
65
Gentex
GNTX
$4.98B
$1.04M 0.07%
65,730
-2,800
-4% -$44.7K
FDS icon
66
Factset
FDS
$9.78B
$1.02M 0.06%
9,475
-135,687
-93% -$14.3M
IBM icon
67
IBM
IBM
$220B
$764K 0.05%
4,153
-1,412
-25% -$249K
UNP icon
68
Union Pacific
UNP
$176B
$713K 0.05%
7,600
-1,800
-19% -$160K
GRMN
69
Garmin
GRMN
$58.5B
$605K 0.04%
10,940
-1,700
-13% -$84.1K
JNJ icon
70
Johnson & Johnson
JNJ
$619B
$601K 0.04%
6,114
-300
-5% -$27.8K
PFE icon
71
Pfizer
PFE
$148B
$599K 0.04%
19,640
-2,689
-12% -$80.2K
MYGN icon
72
Myriad Genetics
MYGN
$295M
$549K 0.03%
16,050
-3,030
-16% -$93.9K
VRSK icon
73
Verisk Analytics
VRSK
$24.6B
$549K 0.03%
9,155
-200
-2% -$12.7K
ABBV icon
74
AbbVie
ABBV
$432B
$537K 0.03%
10,440
-1,110
-10% -$56.1K
CVX icon
75
Chevron
CVX
$372B
$502K 0.03%
4,224
-1,544
-27% -$180K

Similar funds

Conestoga Capital Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Conestoga Capital Advisors held 140 positions worth $1.58B, up 6.2% from $1.49B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors deployed $199M of net new capital in Q1 2014, opening 2 new positions and adding to 50 existing holdings. Its largest new stake was Cantel Medical Corporation: 444,000 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was CoStar Group, an estimated $16.9M trimmed.

  • Conestoga Capital Advisors's largest Q1 2014 buy was Cantel Medical Corporation: 444,000 shares worth $15M.
  • Conestoga Capital Advisors added most to Dorman Products in Q1 2014, an estimated $21.5M increase.
  • Conestoga Capital Advisors's biggest Q1 2014 reduction was CoStar Group, cutting an estimated $16.9M.
  • Conestoga Capital Advisors fully exited Accelrys Inc in Q1 2014, selling an estimated $20.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.58B portfolio in Q1 2014.
  • Conestoga Capital Advisors opened 2 new positions and closed 5 in Q1 2014.
  • Conestoga Capital Advisors's portfolio value rose 6.2% quarter-over-quarter to $1.58B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.